Standard PSA tests or MRI scans aren’t good enough on their own to find dangerous prostate cancers in men with BRCA mutations—they need better ways to tell who’s really at risk.

1

Pro

0

Against

Evidence from Studies

Supporting (1)

1

Community contributions welcome

1

Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations

Narrative Review

2023 Apr

The study says that checking PSA levels or doing an MRI alone isn’t good enough to find dangerous prostate cancer in men with BRCA1/2 mutations — they need better ways to figure out who’s really at risk.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations

Score: 1

DOI: 10.1038/s41585-022-00680-4

Similar Assertions

Doctors should bring up PSA testing early with men who are more likely to get prostate cancer—like Black men or those with a family history—instead of waiting for the patient to ask.

1

0

75%

The PSA blood test isn't very good at telling the difference between harmless prostate changes and real cancer, so many men get scared and undergo painful tests they don't need.

1

0

73%

We don’t yet know if screening men with BRCA mutations for prostate cancer actually saves lives or improves how they feel long-term.

1

0

71%

Having a BRCA1 mutation raises prostate cancer risk, but not as much as having a BRCA2 mutation.

1

0

71%